RepurpSS-II study
Leflunomide and Hydroxychloroquine combination therapy for primary Sjögren’s Syndrome
Randomized double-blind, placbo-controlled mono-center clinical trial with leflunomide/hydrochloroquinine combination therapy in patients with primary Sjogren's syndrome, testing the ffct on disease activity.
Contact
Safae Hamkour